Cetera Investment Advisers’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Cetera Investment Advisers’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Sell	8,502 -11,960	-58%	-$1.29M	﹤0.01%	3053
2026 Q1	$2.12M	Buy	20,462 +14,628	+251%	+$1.55M	﹤0.01%	2233
2025 Q4	$610K	Sell	5,834 -139	-2%	-$14K	﹤0.01%	3257
2025 Q3	$552K	Buy	5,973 +5	+0.1%	+$438	﹤0.01%	3301
2025 Q2	$477K	Sell	5,968 -272	-4%	-$21.7K	﹤0.01%	3009
2025 Q1	$541K	Buy	6,240 +702	+13%	+$59.8K	﹤0.01%	2776
2024 Q4	$458K	Sell	5,538 -743	-12%	-$63.9K	﹤0.01%	2755
2024 Q3	$546K	Buy	6,281 +476	+8%	+$40.7K	﹤0.01%	2584
2024 Q2	$477K	Buy	5,805 +27	+0.5%	+$2.15K	﹤0.01%	2627
2024 Q1	$463K	Buy	+5,778	New	+$448K	﹤0.01%	2659

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Cetera Investment Advisers's PJP Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Invesco Pharmaceuticals ETF (PJP) stake by 58% in Q2 2026, selling an estimated $1.29M and leaving 8,502 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3053.

Cetera Investment Advisers first reported a position in PJP in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.12M in Q1 2026. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Cetera Investment Advisers held 8,502 shares of Invesco Pharmaceuticals ETF worth $1.01M as of Q2 2026.
Cetera Investment Advisers sold 11,960 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.29M.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3053 holding.
Cetera Investment Advisers first reported a position in Invesco Pharmaceuticals ETF in Q1 2024 and has held it in 10 quarters since.
Cetera Investment Advisers's Invesco Pharmaceuticals ETF position peaked at $2.12M in Q1 2026.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.